Atıf İçin Kopyala
Ergun Y., Esen S. A., Bardakci M., Ucar G., Kalkan Z., Urakci Z., ...Daha Fazla
CANCER BIOMARKERS, cilt.34, sa.2, ss.329-336, 2022 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
34
Sayı:
2
-
Basım Tarihi:
2022
-
Doi Numarası:
10.3233/cbm-210455
-
Dergi Adı:
CANCER BIOMARKERS
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
-
Sayfa Sayıları:
ss.329-336
-
Anahtar Kelimeler:
Immune checkpoint inhibitor, nivolumab, ABO blood group, predictive, biomarker, TUMOR-NECROSIS-FACTOR, CANCER RISK, SURVIVAL, ASSOCIATION
-
Gazi Üniversitesi Adresli:
Evet
Özet
BACKGROUND: The relationship of the ABO blood group system with the immune response is known, but its relationship with immune checkpoint inhibitors (ICIs) has not been clearly investigated until now.